Sundial Growers Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sundial Growers in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Sundial Growers stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNDL, but not buy additional shares or sell existing shares.
View analyst ratings for Sundial Growers or view top-rated stocks.

Wall Street analysts have given Sundial Growers a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sundial Growers wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Sundial Growers saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 106,380,000 shares, an increase of 46.1% from the January 28th total of 72,810,000 shares. Based on an average daily trading volume, of 586,800,000 shares, the short-interest ratio is presently 0.2 days.
View Sundial Growers' Short Interest.

Sundial Growers is scheduled to release its next quarterly earnings announcement on Wednesday, March 17th 2021.
View our earnings forecast for Sundial Growers.

Sundial Growers will be holding an earnings conference call on Wednesday, March 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Sundial Growers Inc. (NASDAQ:SNDL) released its quarterly earnings results on Friday, May, 15th. The company reported ($0.41) EPS for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.16. The firm had revenue of $23.04 million for the quarter. Sundial Growers had a negative net margin of 415.89% and a negative trailing twelve-month return on equity of 187.67%.
View Sundial Growers' earnings history.

Sundial Growers' stock was trading at $0.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SNDL stock has increased by 26.9% and is now trading at $1.1550.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued twelve-month target prices for Sundial Growers' shares. Their forecasts range from $1.00 to $1.00. On average, they expect Sundial Growers' share price to reach $1.00 in the next year. This suggests that the stock has a possible downside of 13.4%.
View analysts' price targets for Sundial Growers or view top-rated stocks among Wall Street analysts.

3 employees have rated Sundial Growers CEO Torsten Kuenzlen on Glassdoor.com. Torsten Kuenzlen has an approval rating of 30% among Sundial Growers' employees. This puts Torsten Kuenzlen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Sundial Growers include STADA Arzneimittel Aktiengesellschaft (STDAF), Aphria (APHA), Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), HEXO (HEXO), ChromaDex (CDXC), Canopy Rivers (RIV), Charlie's (CHUC), MediWound (MDWD), Natural Alternatives International (NAII), Nutra Pharma (NPHC), Glucose Health (GLUC) and Happiness Biotech Group (HAPP).
View all of SNDL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sundial Growers investors own include (CGC), OrganiGram (OGI), (HEXO), Aurora Cannabis (ACB), Genius Brands International (GNUS), Onconova Therapeutics (ONTX), Top Ships (TOPS), (APHA), Cronos Group (CRON) and Sorrento Therapeutics (SRNE).

(SNDL) raised $130 million in an initial public offering on Thursday, August 1st 2019. The company issued 10,000,000 shares at $12.00-$14.00 per share. Cowen, BMO Capital Markets and Barclays acted as the underwriters for the IPO.

Sundial Growers trades on the NASDAQ under the ticker symbol "SNDL."

Sundial Growers' stock is owned by many different institutional and retail investors. Top institutional shareholders include Jane Street Group LLC (0.07%), CAPROCK Group Inc. (0.05%), Squarepoint Ops LLC (0.03%), Scotia Capital Inc. (0.02%), GSA Capital Partners LLP (0.01%) and Strategic Wealth Management Group LLC (0.01%).

SNDL stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Squarepoint Ops LLC, CAPROCK Group Inc., GSA Capital Partners LLP, Strategic Wealth Management Group LLC, FNY Investment Advisers LLC, and Scotia Capital Inc..

Shares of SNDL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNDL stock can currently be purchased for approximately $1.16.

Sundial Growers has a market capitalization of $1.80 billion and generates $75.86 million in revenue each year. The company earns $-204,570,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis.

Sundial Growers employs 868 workers across the globe.

The official website for Sundial Growers is www.sundialcannabis.com.

Sundial Growers is headquartered at 919 11 AVENUE SW SUITE 200, CALGARY A0, T2R1P3.

Sundial Growers' mailing address is 919 11 AVENUE SW SUITE 200, CALGARY A0, T2R1P3. The company can be reached via phone at 403-948-5227 or via email at [email protected]